Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis

Neurological Sciences

Volumn 30, Issue 6, 2009, Pages 531-534

  Centonze, Diego ^a,b   Mori, Francesco ^a,b   Koch, Giacomo ^a,b   Buttari, Fabio ^a,b   Codecà, Claudia ^a,b   Rossi, Silvia ^a,b   Cencioni, Maria Teresa ^b   Bari, Monica ^a   Fiore, Stefania ^a,b   Bernardi, Giorgio ^a,b   Battistini, Luca ^b   MacCarrone, Mauro ^b,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF TERAMO   (Italy)

Author keywords

Endocannabinoid system; H reflex; Inflammation; Pain; Sativex ; Spasticity

Indexed keywords

ANANDAMIDE; ANTIDEPRESSANT AGENT; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABIS; FATTY ACID AMIDASE; GABAPENTIN; PHOSPHOLIPASE D; PREGABALIN;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FEMALE; HALLUCINOSIS; HOFFMANN REFLEX; HUMAN; INFLAMMATION; MALE; MOTOR UNIT POTENTIAL; MULTIPLE SCLEROSIS; NAUSEA; NEUROPATHIC PAIN; PAIN ASSESSMENT; PERIPHERAL LYMPHOCYTE; SEDATION; SIDE EFFECT; SOLEUS MUSCLE; SPASTICITY; VISUAL ANALOG SCALE;

ADULT; ARACHIDONIC ACIDS; CANNABINOIDS; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; PAIN; PLANT EXTRACTS; POLYUNSATURATED ALKAMIDES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; REFLEX, STRETCH; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70449533773     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-009-0136-5     Document Type: Article

References (8)

1. D Baker G Pryce G Giovannoni AJ Thompson 2003 The therapeutic potential of cannabis Lancet Neurol 2 291 298 10.1016/S1474-4422(03)00381-8 1:CAS:528:DC%2BD3sXms1yhtro%3D 12849183 (Pubitemid 38368569)
2. D Centonze M Bari S Rossi C Prosperetti R Furlan F Fezza V De Chiara L Battistini G Bernardi S Bernardini G Martino M Maccarrone 2007 The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis Brain 130 2543 2553 10.1093/brain/awm160 17626034 (Pubitemid 47511703)
3. C Collin P Davies IK Mutiboko S Ratcliffe 2007 Sativex spasticity in MS Study Group. Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis Eur J Neurol 14 290 296 1:STN:280:DC%2BD2s7lsFOksA%3D%3D 17355549
4. D Centonze G Koch V Versace F Mori S Rossi L Brusa K Grossi F Torelli C Prosperetti A Cervellino GA Marfia P Stanzione MG Marciani L Boffa G Bernardi 2007 Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis Neurology 68 1045 1050 10.1212/01.wnl.0000257818.16952.62 1:STN:280:DC%2BD2s7ovVWnug%3D%3D 17389310 (Pubitemid 46569140)
5. DJ Rog TJ Nurmikko T Friede CA Young 2005 Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis Neurology 65 812 819 10.1212/01.wnl.0000176753.45410.8b 16186518 (Pubitemid 41362120)
6. Conte A, Bettolo CM, Onesti E, Frasca V, Iacovelli E, Gilio F, Giacomelli E, Gabriele M, Aragona M, Tomassini V, Pantano P, Pozzilli C, Inghilleri M (2008) Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis. Eur J Pain [Epub ahead of print]
7. International Association for Cannabis as Medicine (IACM) bulletin of 13 April 2008
8. D Baker G Pryce JL Croxford P Brown RG Pertwee JW Huffman L Layward 2000 Cannabinoids control spasticity and tremor in a multiple sclerosis model Nature 404 84 87 10.1038/35003583 1:CAS:528:DC%2BD3cXhvVyqsb4%3D 10716447 (Pubitemid 30143137)